Navigation Links
Anesthetic Drugs Procurement Research Report Now Available from IBISWorld
Date:1/1/2014

Los Angeles, California (PRWEB) January 01, 2014

Anesthetic drugs have a buyer power score of 2.5 out of 5. The score reflects current negative pricing trends and indicates a moderate level of buyer bargaining power. “Prices for anesthetics have fluctuated over the past three years as a result of rising regulatory compliance costs and generics competition,” says IBISWorld procurement analyst Anna Son. The patent expiration of many blockbuster drugs has increased availability of generic anesthetics, which are typically far less expensive than their brand-name counterparts, thus helping to mitigate price growth over the past three years. Nevertheless, a limited number of suppliers of anesthetics that are in short supply, such as propofol, has kept prices high due to the constrained supply of those drugs.

The cost associated with switching anesthetics suppliers varies depending on the type of supplier. For example, buyers can expect lower switching costs associated with suppliers of commonly used anesthetics, such as ketamine, because of their instant availability and low buying lead time. “This provides buyers with the opportunity to restock their inventory in a relatively short time frame, barring contract negotiations,” says Son. In this case, buyers of anesthetic drugs have greater leverage in negotiating contracts. On the contrary, buyers are more likely to incur higher costs when they switch suppliers of anesthetics that are in short supply, especially when there are only a small number of suppliers of that particular drug. As such, suppliers of rare anesthetics have greater negotiating power over buyers. Some of the major vendors include Abbott Laboratories, Baxter International Inc., Fresenius Kabi AG and Hospira Inc.

Furthermore, anesthetic manufacturers typically capture high profit margins. High margins usually give buyers room to negotiate for lower prices. However, the low availability of substitutes, a moderate level of market share concentration and the high specialization among suppliers limit buyers' negotiating power. In addition, the anesthetics market is mature and has a low level of financial risk, given its established place in the supply chain.

For more information, visit IBISWorld’s anesthetic drugs procurement research report page.

Follow IBISWorld on Twitter: https://twitter.com/#!/IBISWorld
Friend IBISWorld on Facebook: http://www.facebook.com/pages/IBISWorld/121347533189

IBISWorld Procurement Report Key Topics

This report is intended to assist buyers of anesthetic drugs. Anesthetic drugs are medicines used to produce anesthesia or loss of normal sensation or feeling and are generally administrated to facilitate surgery. Anesthetic drugs can be grouped into two classes: general anesthetics, which cause a reversible loss of consciousness, and local anesthetics, which cause a reversible loss of sensation in a particular area of the body while maintaining consciousness.

Executive Summary
Pricing Environment
Price Fundamentals
Benchmark Price
Pricing Model
Price Drivers
Recent Price Trend
Price Forecast
Product Characteristics
Product Life Cycle
Total Cost of Ownership
Product Specialization
Substitute Goods
Regulation
Quality Control
Supply Chain & Vendors
Supply Chain Dynamics
Supply Chain Risk
Imports
Competitive Environment
Market Share Concentration
Vendor Financial Benchmarks
Switching Costs
Purchasing Process
Buying Basics
Buying Lead Time
Selection Process
Key RFP Elements
Negotiation Questions
Buyer Power Factors
Key Statistics

About IBISWorld Inc.
IBISWorld is one of the world's leading publishers of business intelligence, specializing in Industry research and Procurement research. Since 1971, IBISWorld has provided thoroughly researched, accurate and current business information. With an extensive online portfolio, valued for its depth and scope, IBISWorld’s procurement research reports equip clients with the insight necessary to make better purchasing decisions, faster. Headquartered in Los Angeles, IBISWorld Procurement serves a range of business, professional service and government organizations through more than 10 locations worldwide. For more information, visit http://www.ibisworld.com or call 1-800-330-3772.

Read the full story at http://www.prweb.com/releases/2014/01/prweb11454217.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Common anesthetic agents can be harmful for the development of the fetus
2. Southlake Dermatology Offers New Pliaglis Anesthetic Cream
3. Recent Study Shows Anesthetic Combination Allows For Quicker Recovery Post Oral Surgery, Tyler Sedation Dentist, Dr. Roy Smith, Comments
4. Pharmacy Robots Linked to Bacterial Contamination of Drugs
5. Penn study cautions use of drugs to block niacin flush
6. Urinary Incontinence Drugs May Be More Trouble Than Theyre Worth
7. Discovery could help to develop drugs for organ transplant and cancer patients
8. Not taking gastroprotective drugs prescribed with anti-inflammatory medicines
9. Live imaging shows response to cancer drugs can be boosted by altering tumor microenvironment
10. Weight-Loss Surgery Beat Drugs for Cutting Diabetes in Very Obese
11. Seniors Stop Taking Heart Drugs In Medicare Donut Hole
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/2/2016)... , ... May 02, 2016 , ... The 2016 World Ultimate & Guts Championship (WUGC) ... at Manhattan College, made the cut. The WUGC is being held in London, England this ... the gold in the men’s division, another gold in the women’s masters division, and a ...
(Date:5/2/2016)... ... , ... Pregnancy Awareness Month offers a great time to get familiar with ... are ready to have a baby, it’s best to get started before age becomes ... Personal Conception & Pregnancy Organizer, written for women who plan on becoming pregnant to ...
(Date:5/2/2016)... ... May 02, 2016 , ... A ... completed two groundbreaking studies that determined that the adjustability and adaptability of pediatric ... the prevention of pressure injuries, which are now referred to as “pressure injuries” ...
(Date:5/2/2016)... ... May 02, 2016 , ... Atlantic Information Services, Inc. (AIS) ... B Payment Model Could Transform the Pharma Landscape .” CMS recently proposed a test ... spend on provider-administered drugs while preserving care provided to beneficiaries. The webinar will review ...
(Date:5/2/2016)... ... May 02, 2016 , ... The Evolve Paddle Board Company- ... prices announced today the outcome of their partnership with Yoloha Yoga- producers of high ... Yoga Board.” , SUP yoga has seen a dramatic rise in popularity throughout the ...
Breaking Medicine News(10 mins):
(Date:4/29/2016)... PUNE, India , April 29, 2016 /PRNewswire/ ... - Pipeline Review, H1 2016" market research report ... pipeline, complete with comparative analysis at various stages, ... (MoA), route of administration (RoA) and molecule type, ... press releases. It also reviews key players involved ...
(Date:4/29/2016)... Glycotope GmbH, a clinical-stage immuno-oncology company built ... Dr. Alfredo Zurlo as Chief Medical Officer. ... years clinical experience and a proven track record in ... at Mologen AG where he was Chief Medical Officer ... held various positions at F Hoffmann La Roche and ...
(Date:4/28/2016)... NEW YORK , April 28, 2016 /PRNewswire/ ... will notably complement the company,s valve repair and ... the move also places Abbott more firmly into ... one of the fastest growing device areas, with ... to its recent report,  Advanced Remote Patient ...
Breaking Medicine Technology: